Healthcare -
Biotechnology - NASDAQ - US
$ 54.4243
4.44 %
$ 3.37 B
Market Cap
69.0
P/E
PTGX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PTGX - Protagonist Therapeutics, Inc.
25.9 M
LAST VALUE
17.15%
2 YEAR CAGR
-10.90%
5 YEAR CAGR
11.13%
10 YEAR CAGR